Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2020

01-08-2020 | Letter to the Editor

From an out-of-date experience

Authors: Gholam Reza Pishdad, Reza Pishdad, Parisa Pishdad

Published in: Endocrine | Issue 2/2020

Login to get access

Excerpt

Favorable diabetes outcomes with efficacious diabetes care require a comprehensive physician-patient communication and shared decision-making [1, 2]. Here, unexpected consequences are always a possibility if the subtleties of the patient-physician relationship are not duly taken into account. …
Literature
1.
E.A. Beverly, O.P. Ganda, M.D. Ritholz, Y. Lee, K.M. Brooks, N.F. Lewis-Schroeder, M. Hirose, K. Weinger, Look who’s (not) talking: diabetic patients’ willingness to discuss self-care with physicians. Diabetes Care 35, 1466–1472 (2012)CrossRef
2.
W.H. Polonsky, M. Capehorn, A. Belton, S. Down, A. Alzaid, V. Gamerman, F. Nagel, J. Lee, S. Edelman, Physician-patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study. Diabetes Res Clin. Pr. 127, 265–274 (2017)CrossRef
3.
E.J. van Bommel, M.H. Muskiet, L. Tonneijck, M.H. Kramer, M. Nieuwdorp, D.H. van Raalte, SGLT2 inhibition in the diabetic kidney from mechanisms to clinical outcome. Clin. J. Am. Soc. Nephrol. 12, 700–710 (2017)CrossRef
Metadata
Title
From an out-of-date experience
Authors
Gholam Reza Pishdad
Reza Pishdad
Parisa Pishdad
Publication date
01-08-2020
Publisher
Springer US
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02231-6

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue

Original Article

Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective

Original Article

Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a 13-year retrospective review at Jordan University Hospital

Original Article

Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease

Meta-Analysis

Socioeconomic differences in hyperuricemia and gout: a systematic review and meta-analysis

Endocrine Surgery

Intrapericardial parathyroid carcinoma: a case report

Original Article

Post-transplant diabetes mellitus: incidence, predicting factors and outcomes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits